Mounjaro price increase leaves UK patients facing big bills

Mounjaro is the brand name for tirzepatide, a medicine that mimics hormones in your body to help control blood sugar and reduce appetite. It’s given by weekly injection and is licensed for type 2 diabetes and for weight loss and weight management in adults aged 18 and over.


This is a companion discussion topic for the original article at https://patient.info/news-and-features/mounjaro-price-rise